Showing results (41-50 of 180) with videos related to
Sort By:
Pageof 18
Blood Cancer Journal|March 16, 2023
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemicJonathan Carmichael, Frances Seymour, Graham McIlroy, et al.Blood Cancer Journal|October 15, 2020
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamicsPhuc H Hoang, Alex J Cornish, Amy L Sherborne, et al.British Journal of Haematology|December 19, 2018
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphomaSimon Rule, Gordon Cook, Nigel H Russell, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2011
Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation RegistryGordon Cook, Effie Liakopoulou, Rachel Pearce, et al.Cancer Immunology, Immunotherapy : CII|December 22, 2009
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linkedMarie von Lilienfeld-Toal, Susanne Frank, Christiane Leyendecker, et al.Leukemia|October 16, 2019
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trialCharlotte Pawlyn, David Cairns, Martin Kaiser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphomaKirsty J Thomson, Emma C Morris, Adrian Bloor, et al.BMC Medical Research Methodology|June 30, 2018
The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myelomaSusanne Schmitz, Áine Maguire, James Morris, et al.BMJ Open|May 11, 2026
Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems dataLesley Smith, Janice Hoang, Sharon Gillson, et al.Haematologica|December 10, 2020
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trialCharlotte Pawlyn, David Cairns, Tom Menzies, et al.Pageof 18